Metadata
Author: WikiMatrix
Data
English[en]
The act applied similar penalties to the interstate marketing of "adulterated" drugs, in which the "standard of strength, quality, or purity" of the active ingredient was not either stated clearly on the label or listed in the United States Pharmacopoeia or the National Formulary.
Chinese[zh]
该法案也对跨州销售的“掺杂”药物施以类似的处罚,这里的“掺杂”是指该药物中活性成分的“强度、品质和纯度指标”未在标签上表明或未出现于《美国药典/国家处方集》(USP/NF)中。